Research ArticleBehavioral Pharmacology
M1 and M2 Muscarinic Receptor Subtypes Regulate Antidepressant-Like Effects of the Rapidly Acting Antidepressant Scopolamine
J. M. Witkin, C. Overshiner, X. Li, J. T. Catlow, G. N. Wishart, D. A. Schober, B. A. Heinz, A. Nikolayev, V. V. Tolstikov, W. H. Anderson, R. E. Higgs, M.-S. Kuo and C. C. Felder
Journal of Pharmacology and Experimental Therapeutics November 2014, 351 (2) 448-456; DOI: https://doi.org/10.1124/jpet.114.216804
J. M. Witkin
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana; and Lilly Research Laboratories, Eli Lilly and Company, Windlesham, Surrey, United Kingdom
C. Overshiner
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana; and Lilly Research Laboratories, Eli Lilly and Company, Windlesham, Surrey, United Kingdom
X. Li
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana; and Lilly Research Laboratories, Eli Lilly and Company, Windlesham, Surrey, United Kingdom
J. T. Catlow
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana; and Lilly Research Laboratories, Eli Lilly and Company, Windlesham, Surrey, United Kingdom
G. N. Wishart
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana; and Lilly Research Laboratories, Eli Lilly and Company, Windlesham, Surrey, United Kingdom
D. A. Schober
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana; and Lilly Research Laboratories, Eli Lilly and Company, Windlesham, Surrey, United Kingdom
B. A. Heinz
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana; and Lilly Research Laboratories, Eli Lilly and Company, Windlesham, Surrey, United Kingdom
A. Nikolayev
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana; and Lilly Research Laboratories, Eli Lilly and Company, Windlesham, Surrey, United Kingdom
V. V. Tolstikov
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana; and Lilly Research Laboratories, Eli Lilly and Company, Windlesham, Surrey, United Kingdom
W. H. Anderson
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana; and Lilly Research Laboratories, Eli Lilly and Company, Windlesham, Surrey, United Kingdom
R. E. Higgs
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana; and Lilly Research Laboratories, Eli Lilly and Company, Windlesham, Surrey, United Kingdom
M.-S. Kuo
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana; and Lilly Research Laboratories, Eli Lilly and Company, Windlesham, Surrey, United Kingdom
C. C. Felder
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana; and Lilly Research Laboratories, Eli Lilly and Company, Windlesham, Surrey, United Kingdom
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleBehavioral Pharmacology
M1 and M2 Muscarinic Receptor Subtypes
J. M. Witkin, C. Overshiner, X. Li, J. T. Catlow, G. N. Wishart, D. A. Schober, B. A. Heinz, A. Nikolayev, V. V. Tolstikov, W. H. Anderson, R. E. Higgs, M.-S. Kuo and C. C. Felder
Journal of Pharmacology and Experimental Therapeutics November 1, 2014, 351 (2) 448-456; DOI: https://doi.org/10.1124/jpet.114.216804
Research ArticleBehavioral Pharmacology
M1 and M2 Muscarinic Receptor Subtypes
J. M. Witkin, C. Overshiner, X. Li, J. T. Catlow, G. N. Wishart, D. A. Schober, B. A. Heinz, A. Nikolayev, V. V. Tolstikov, W. H. Anderson, R. E. Higgs, M.-S. Kuo and C. C. Felder
Journal of Pharmacology and Experimental Therapeutics November 1, 2014, 351 (2) 448-456; DOI: https://doi.org/10.1124/jpet.114.216804
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement